Actively Recruiting
Using Induced-Pluripotent Stem Cells to Model Cancer Therapy-Related Adverse Events
Led by Mayo Clinic · Updated on 2026-01-06
30
Participants Needed
1
Research Sites
100 weeks
Total Duration
On this page
AI-Summary
What this Trial Is About
This study is being done to find out if patient blood samples can be used to perform individualized modeling of cancer therapy-related side effects.
CONDITIONS
Official Title
Using Induced-Pluripotent Stem Cells to Model Cancer Therapy-Related Adverse Events
Who Can Participate
Eligibility Criteria
You may qualify if you...
- Any patient 18 years of age or older
- Previously treated, planned, or currently receiving any potentially toxic cancer therapy including chemotherapy, targeted therapies, or immunotherapies
You will not qualify if you...
- Unable to understand the informed consent or comply with the study protocol
AI-Screening
AI-Powered Screening
Complete this quick 3-step screening to check your eligibility
Trial Site Locations
Total: 1 location
1
Mayo Clinic in Florida
Jacksonville, Florida, United States, 32224-9980
Actively Recruiting
Research Team
C
Clinical Trials Referral Office
CONTACT
How is the study designed?
Study Type
OBSERVATIONAL
Masking
N/A
Allocation
N/A
Model
N/A
Primary Purpose
N/A
Number of Arms
1
Not the Right Trial for You?
Explore thousands of other clinical trials that might be a better match.
Sign up to get personalized trial recommendations delivered to your inbox.
Already have an account? Log in here